Mumbai: Swiss pharma major Novartis today said it will not invest on research and development in India and move R&D to favourable destinations following the Supreme Court order rejecting its pate

The Supreme Court will hear final arguments in a landmark case over drug patents that could change the rules for the country's healthcare sector and potentially curb its global role as a supplier of c